Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA

The article discusses the results of modern studies evaluating the effectiveness of drug therapy for heart failure with reduced ejection fraction (HFrEF). Modern approaches to a comprehensive evaluation of data obtained in various randomized clinical trials (RCTs) are presented. The role of methods...

Full description

Saved in:
Bibliographic Details
Main Authors: S. R. Gilyarevsky, Yu. V. Mareev
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5422
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849341264270458880
author S. R. Gilyarevsky
Yu. V. Mareev
author_facet S. R. Gilyarevsky
Yu. V. Mareev
author_sort S. R. Gilyarevsky
collection DOAJ
description The article discusses the results of modern studies evaluating the effectiveness of drug therapy for heart failure with reduced ejection fraction (HFrEF). Modern approaches to a comprehensive evaluation of data obtained in various randomized clinical trials (RCTs) are presented. The role of methods for presenting the RCT results is considered, as well as the difference between hazard ratio and relative risk is clarified. Expert opinions are discussed about the limitations of simplified approaches to comparing the results of large RCTs, which are based only on comparisons of hazard ratio without taking consideration of patient characteristics, study duration, and the absolute number of adverse outcomes that developed. Information is provided on the role of accounting for multiple comparisons in assessing clinical outcomes in RCTs. The article compares the VICTORIA results on the study of vericiguat in patients with a recent episode of HFrEF decompensation with RCTs on the evaluation of the effects of drugs that are part of standard therapy.
format Article
id doaj-art-0f22931e43f64708be53e271690f83b9
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2023-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-0f22931e43f64708be53e271690f83b92025-08-20T03:43:40Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-06-0128510.15829/1560-4071-2023-54223809Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIAS. R. Gilyarevsky0Yu. V. Mareev1Russian Medical Academy of Continuing Professional EducationNa­­tional Medical Research Center for Preventive MedicineThe article discusses the results of modern studies evaluating the effectiveness of drug therapy for heart failure with reduced ejection fraction (HFrEF). Modern approaches to a comprehensive evaluation of data obtained in various randomized clinical trials (RCTs) are presented. The role of methods for presenting the RCT results is considered, as well as the difference between hazard ratio and relative risk is clarified. Expert opinions are discussed about the limitations of simplified approaches to comparing the results of large RCTs, which are based only on comparisons of hazard ratio without taking consideration of patient characteristics, study duration, and the absolute number of adverse outcomes that developed. Information is provided on the role of accounting for multiple comparisons in assessing clinical outcomes in RCTs. The article compares the VICTORIA results on the study of vericiguat in patients with a recent episode of HFrEF decompensation with RCTs on the evaluation of the effects of drugs that are part of standard therapy.https://russjcardiol.elpub.ru/jour/article/view/5422heart failureevaluation of research resultsvericiguatcomparison of re­­search results
spellingShingle S. R. Gilyarevsky
Yu. V. Mareev
Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA
Российский кардиологический журнал
heart failure
evaluation of research results
vericiguat
comparison of re­­search results
title Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA
title_full Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA
title_fullStr Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA
title_full_unstemmed Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA
title_short Modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy. Analysis of the results of randomized trials PARADIGM-HF, DAPA-HF, EMPEROR-Reduced and VICTORIA
title_sort modern approaches to interpretation of clinical trial results to evaluate the effectiveness of heart failure therapy analysis of the results of randomized trials paradigm hf dapa hf emperor reduced and victoria
topic heart failure
evaluation of research results
vericiguat
comparison of re­­search results
url https://russjcardiol.elpub.ru/jour/article/view/5422
work_keys_str_mv AT srgilyarevsky modernapproachestointerpretationofclinicaltrialresultstoevaluatetheeffectivenessofheartfailuretherapyanalysisoftheresultsofrandomizedtrialsparadigmhfdapahfemperorreducedandvictoria
AT yuvmareev modernapproachestointerpretationofclinicaltrialresultstoevaluatetheeffectivenessofheartfailuretherapyanalysisoftheresultsofrandomizedtrialsparadigmhfdapahfemperorreducedandvictoria